Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 18, 2025, ABIONYX Pharma SA (ABNX.PA) has a market cap of $47.288 million USD. According to our data, ABIONYX Pharma SA is ranked No.8114 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 18, 2025 | $47.29 M |
0.67%
|
| Dec 31, 2024 | $46.97 M |
-7.61%
|
| Dec 29, 2023 | $50.84 M |
-25.20%
|
| Dec 30, 2022 | $67.97 M |
-29.57%
|
| Dec 31, 2021 | $96.51 M |
147.22%
|
| Dec 31, 2020 | $39.04 M |
193.47%
|
| Dec 31, 2019 | $13.30 M |
-31.22%
|
| Dec 31, 2018 | $19.34 M |
-74.35%
|
| Dec 29, 2017 | $75.39 M |
-77.92%
|
| Dec 30, 2016 | $0.34 B |
-32.00%
|
| Dec 30, 2015 | $0.50 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$149.09 B |
0.124 B
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
USA
|
 Biogen
BIIB
|
$17.36 B |
-0.001 M
|
USA
|
 Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$125.74 B |
-0.003 M
|
USA
|
 Moderna
MRNA
|
$9.56 B |
-0.000 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.35 B |
0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.22 B |
0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$30.36 B |
0.000 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$4.51 B |
-0.000 M
|
USA
|
 Incyte
INCY
|
$11.27 B |
0.000 M
|
USA
|
 Ultragenyx
RARE
|
$3.35 B |
0.000 M
|
USA
|
 Blueprint Medicines
BPMC
|
$5.41 B |
0.000 M
|
USA
|
| Market Cap | = | ABNX.PA Stock Price | * | ABNX.PA Shares Outstanding |
| = | $1.37 | * | 34.64 M | |
| = | $47.29 M |